“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB‐FUBINACA in New York

@article{Adams2017ZombieOC,
  title={“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB‐FUBINACA in New York},
  author={Axel Adams and Samuel D. Banister and Lisandro Irizarry and Jordan Trecki and Michael David Schwartz and Roy R. Gerona},
  journal={The New England Journal of Medicine},
  year={2017},
  volume={376},
  pages={235–242}
}
BACKGROUND New psychoactive substances constitute a growing and dynamic class of abused drugs in the United States. On July 12, 2016, a synthetic cannabinoid caused mass intoxication of 33 persons in one New York City neighborhood, in an event described in the popular press as a “zombie” outbreak because of the appearance of the intoxicated persons. METHODS We obtained and tested serum, whole blood, and urine samples from 8 patients among the 18 who were transported to local hospitals; we also… Expand
Fatal intoxication with new synthetic cannabinoids AMB-FUBINACA and EMB-FUBINACA
TLDR
The presented case shows that synthetic cannabinoids can be undetected in the blood of even seriously or fatally intoxicated people and suggests that AMB-FUBINACA and EMB-FubINACA use is dangerous to health and may lead to fatal intoxication. Expand
A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?
TLDR
The present case can be discussed as an example of both drug-induced and drug-related death resulting from acute intoxication with 5F-ADB and FUB-AMB as well as from systematic use of both synthetic cannabinoids. Expand
Synthetic cannabinoid “Black Mamba” infidelity in patients presenting for emergency stabilization in Colorado: a P SCAN Cohort
TLDR
The wide range of clinical presentations from “Black Mamba” use may be explained by the wide variability of chemical constituents found by laboratory analysis. Expand
4F‐MDMB‐BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework
TLDR
4F‐MDMB‐BINACA is appearing with increasing frequency as a contributory factor in deaths, creating morbidity and mortality risks for drug users, and Laboratories must be aware of its presence and impact, incorporating 4F‐ MDMB‐ BINACA into workflows for detection and confirmation. Expand
Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
TLDR
The findings show that in Kuwait, the most common mix of synthetic cannabinoids is FUB-AMB with 5F-ADB, and 5Cl-AKB-48, and the synthetic cannabinoid types that were associated with six reported deaths are revealed. Expand
The identification and quantification of synthetic cannabinoids seized in New Zealand in 2017.
TLDR
The synthetic cannabinoid AMB-FUBINACA displayed the greatest range of concentration in plant material, from 5 to over 400 g of synthetic cannabinoid per kilogram of plant material. Expand
Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications
TLDR
This review highlights the urgent requirement for additional studies on the toxicokinetic properties of AMB-FUBINACA and ADB- fubINACA, as this is imperative to improve the methods for detecting and quantifying these drugs and to determine the best exposure markers in the various biological matrices. Expand
Screening, quantification, and confirmation of synthetic cannabinoid metabolites in urine by UHPLC–QTOF–MS
TLDR
The UHPLC–QTOF–MS method was proven to be sensitive, selective and robust for routine use for the investigated metabolites, and fulfilled the set criteria and requirements for matrix effect, extraction recovery, linearity, precision, accuracy, specificity, and stability. Expand
Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds-A Stability Assessment.
TLDR
Forensic toxicologists should be aware of the results of this study as they directly impact analytical consideration for test development and implementation, as well as interpretation of findings. Expand
Assessment of Synthetic Cannabinoid FUB-AMB and its Ester Hydrolysis Metabolite in Human Liver Microsomes and Human Blood Samples by UHPLC-MS/MS.
TLDR
The authors propose that M1 is a reliable marker for inclusion in laboratory blood screens for FUB-AMB, and suggest that synthetic cannabinoid laboratory assay panels include metabolites, especially known or potential pharmacologically active metabolites, particularly for compounds with short half-lives. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 30 REFERENCES
An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA
TLDR
A coordinated response and collaboration between law enforcement, the local public health, emergency medical services and Health Center staff, were all key interventions in preventing a more substantial public health outbreak resulting from use of a novel synthetic cannabinoid compound. Expand
A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA.
TLDR
In this outbreak, close cooperation between public health and law enforcement allowed for a rapid intervention, which halted the outbreak by interrupting the common source and accelerated regulatory efforts to prevent further morbidity and mortality. Expand
Death after use of the synthetic cannabinoid 5F-AMB.
TLDR
The death of an individual that was associated with the synthetic cannabinoid 5F-AMB was reported and cause and manner of death was certified as accidental death due to synthetic cannabinoid toxicity. Expand
A survey study to characterize use of Spice products (synthetic cannabinoids).
TLDR
Acute subjective effects were similar to known effects of cannabis, and a subset of users met DSM criteria for abuse and dependence on Spice products, and controlled laboratory research is needed to further examine the behavioral pharmacology of individual synthetic cannabinoids found in Spice products. Expand
Acute kidney injury associated with smoking synthetic cannabinoid
TLDR
The epidemiology of a toxicologic syndrome of acute kidney injury associated with synthetic cannabinoids is described, the toxicologic and public health investigation of the cluster is reviewed, and clinical implications of the Cluster investigation are described. Expand
Effects of acute detoxification of the herbal blend ‘Spice Gold’ on dopamine D2/3 receptor availability: A [18F]fallypride PET study
TLDR
This study shows substantial short-term alterations of dopamine D2/3 receptor availability in a patient before and after acute detoxification from "Spice Gold", thus providing first evidence of reversible effects on dopamine receptors of heavy use of a herbal smoking blend. Expand
Synthetic Cannabinoid Receptor Agonists
Since 2008 dozens of new synthetic cannabinoid receptor agonist compounds have emerged as additives in so-called ‘Spice’ or ‘K2’ products. These synthetic cannabinoid receptor agonists have become aExpand
Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.
TLDR
In vitro functional activities of SC designer drugs JWH-018, UR-144, PB-22, and APICA, and their respective terminally fluorinated analogues and in vivo in vivo cannabinoid type 1 receptor binding affinity evaluated in rats showed no consistent trend for increased potency of fluorinated SCs over the corresponding des-fluoro SCs in vivo. Expand
Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry.
TLDR
The metabolism of AMB and 5F-AMB is investigated and appropriate markers to identify their intake in clinical or forensic cases are proposed, providing valuable data for identifying these two novel psychoactive substances. Expand
Patterns of synthetic cannabinoid use in Australia.
TLDR
The sample reported first using synthetic cannabinoids due to curiosity, legality, availability, effects, non-detection in drug testing and to reduce their cannabis use to aid the reduction or cessation of cannabis use. Expand
...
1
2
3
...